Becton, Dickinson and Company (NYSE:BDX) Cut to “Hold” at Citigroup
Citigroup lowered shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) from a strong-buy rating to a hold rating in a research report released on Thursday, MarketBeat.com reports. They currently have $185.00 price target on the medical instruments supplier’s stock, down from their previous price target of $217.00. Several other research firms have also […]
Citigroup lowered shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) from a strong-buy rating to a hold rating in a research report released on Thursday, MarketBeat.com reports. They currently have $185.00 price target on the medical instruments supplier’s stock, down from their previous price target of $217.00. Several other research firms have also […]
